Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02226107 · ClinicalTrials.gov registry record · NA

Latino Peers as Patient Navigators for Colon Cancer Screening

A NA study of Colon Cancer, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
85
Enrollment target
1
Study location

NCT02226107: Completed NA study of Colon Cancer, sponsored by Icahn School of Medicine at Mount Sinai.

NCT02226107 is a NA study of Colon Cancer that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 85 participants, below the 4,455-participant average among 97 other Colon Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02226107, a NA study of Colon Cancer, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

Disparities among racial and ethnic minorities remain prevalent despite advances in medical science that make thes early detection and prevention of colorectal cancer a possibility for all human kind. It is estimated that 90% of colorectal cancer deaths could be prevented through screening. Unfortunately, among Latinos, colorectal cancer is the second leading cause of cancer death. This rate is influenced by the fact that Latinos have the lowest rates of colorectal cancer screening compared to other US racial groups. Moreover, Latinos are more likely than whites to be diagnosed with advanced-stage colorectal cancer, when treatment options are more limited. Lay health worker interventions for breast and cervical cancer education and screening have demonstrated success in increasing both knowledge and screening rates among racial and ethnic minorities. Additionally, our research has also shown success in training African Americans as peer navigators to increase colorectal cancer screening. Few lay health interventions, however, have been designed specifically for colorectal cancer screening among Latinos. Thus, the purpose of this study is to expand peer navigation for colorectal cancer screening to Latinos and increase their participation in screening by training Latinos, who have had a colonoscopy, to help navigate other Latinos through the colonoscopy screening procedure. This study will focus on expanding the work of our research group by training Latino peers, who are 50 years or older, have had a colonoscopy, and can model successful colonoscopy screening completion to navigate Latino patients for screening. First, a training manual will be developed which will be culturally specific to Latinos. Feedback and input from community members will guide the development of the manual and training program. Second, the training program will be carried out with six bilingual Latino peers, who will be taught to master the core skills of patient navigation for screening co

Primary Outcome

Participants will be given up to four months (including re-scheduling) to complete their colonoscopy after an initial appointment is scheduled.

Conditions Studied

Interventions

  • BEHAVIORAL Peer-PN
  • BEHAVIORAL Pro-PN

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2014-01
Est. Completion 2015-03
Phase NA

What the finished NCT02226107 record still lists

NCT02226107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 4,455-participant average among 97 other Colon Cancer trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Colon Cancer appearing as the primary indexed condition, and to 2 interventions - of which Peer-PN is the first listed.

NCT02226107 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02226107 about?

NCT02226107 is a clinical study titled "Latino Peers as Patient Navigators for Colon Cancer Screening". Disparities among racial and ethnic minorities remain prevalent despite advances in medical science that make thes early detection and prevention of colorectal cancer a possibility for all human kind. It is estimated that 90% of colorectal cancer deaths could be prevented through screening. Unfortun...

What is the current status of trial NCT02226107?

This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2014-01. Estimated completion is 2015-03.

What conditions does trial NCT02226107 study?

This clinical trial studies the following conditions: Colon Cancer.

What interventions are being tested in trial NCT02226107?

The interventions under investigation include: Peer-PN (BEHAVIORAL), Pro-PN (BEHAVIORAL).

Who is sponsoring clinical trial NCT02226107?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02226107 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colon Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02226107's enrollment target sits among peer trials

85 56th of 97 higher than 42 of 97 other Colon Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colon Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00842283 · 85 participants

    Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

  • NCT02133196 · 85 participants · Phase 2

    T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • NCT03823144 · 85 participants · NA

    Intravital Microscopy in Human Solid Tumors

  • NCT03875638 · 85 participants · Phase 2

    Treating Hyperexcitability in AD With Levetiracetam

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02226107, the US trial registry maintained by the National Library of Medicine. NCT02226107 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.